BrightEdge operates at the intersection of investment and innovation to define and catalyze scientific, social, and sustainable impact across the continuum of cancer care. As the innovation and impact investment arm of the American Cancer Society, we identify and thoughtfully invest in scalable solutions addressing unmet needs and generating financial returns to bolster ACS’s lifesaving work.
Deal activity and portfolio updates would appear here
Connect your data source to see recent transactions